Related Experiment Video

Updated: Jul 15, 2026

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

[Hypoglycemia in infancy -- not always of no importance!]

U A Scheidegger1, C E Flück, J M Nuoffer

  • 1Medizinische Universität-Kinderklinik Bern. ursina.scheidegger@insel.ch

Praxis
|April 17, 2007
PubMed

Insights

A six-month-old infant experienced sudden loss of consciousness due to hypoglycemia. Investigations identified hyperinsulinism as the cause, highlighting the importance of prompt diagnosis and management of infant hypoglycemia.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Neonatology

Background:

  • Infantile hypoglycemia, characterized by low blood glucose levels, presents a significant diagnostic challenge in neonates and infants.
  • Sudden loss of consciousness in infants warrants immediate medical evaluation to rule out critical metabolic disturbances.

Observation:

  • A six-month-old male infant presented with acute loss of consciousness.
  • Initial assessment revealed severe hypoglycemia, which was successfully corrected.
  • Further diagnostic workup was initiated to determine the underlying etiology of recurrent hypoglycemic episodes.

Findings:

  • Persistent hyperinsulinism was identified as the primary cause of recurrent hypoglycemia in the infant.
  • This condition involves dysregulated insulin secretion leading to profound hypoglycemia.
  • The case underscores the need for comprehensive investigation beyond initial glucose correction.

Implications:

  • Early and accurate diagnosis of hyperinsulinism is crucial for preventing severe neurological complications associated with hypoglycemia in infants.
  • Understanding the differential diagnosis of hypoglycemia in infancy is essential for guiding appropriate therapeutic strategies.
  • This case highlights the importance of considering specific endocrine disorders in the management of recurrent hypoglycemia in pediatric patients.

More Related Videos

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test06:59

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Published on: November 13, 2016

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...